Also, the germline-specific chromatin regulator ATAD2 drives various cancer progression phenotypes via transcriptional regulation and is linked to poor prognoses in various cancers and offers an important potential therapeutic target [62–72]. This evidence concerns the gene ATAD2 and cancer.